Sheng-Shung Pong

Title: Innovations of Sheng-Shung Pong

Introduction

Sheng-Shung Pong is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of receptor biology, holding a total of three patents. His work focuses on the cloning and identification of various receptors that play crucial roles in gastric conditions.

Latest Patents

One of his latest patents involves the cloning and identification of the motilin receptor. This receptor has been isolated and cloned, with nucleic acid sequences provided. Two splice variants have been identified, and assays for motilin receptor ligands are also included. The identification of the cloned motilin receptor may be utilized to screen and identify compounds that bind to the receptor, which can be beneficial for various gastric conditions, including gastric motility disorders. Another significant patent describes assays for growth hormone secretagogue receptors. This assay detects growth hormone secretagogue receptors and related receptors, which are part of the G protein-coupled receptors family. A subunit of the G protein must be present for expression detection, and a similar assay is described for detecting the presence of growth hormone secretagogues.

Career Highlights

Sheng-Shung Pong is currently employed at Merck & Company, Inc., where he continues to advance his research in receptor biology. His work has implications for understanding and treating gastric motility disorders, showcasing his commitment to improving health outcomes.

Collaborations

He has collaborated with notable coworkers, including Roy G Smith and Scott D Feighner, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sheng-Shung Pong's contributions to receptor biology through his patents and work at Merck & Company, Inc. highlight his role as an influential inventor in the field. His research has the potential to impact the treatment of gastric conditions significantly.